Kantum Pharma
PrivateLast Round
Series A
Jul 12, 2021
Total Funding Raised
$6.73M
Company Overview
Kantum Pharma is a biotechnology company that develops therapeutic treatments and diagnostic tests for acute kidney injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kantum Pharma Comparables
Compare Kantum Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Balmes Transplantation | 78% | |
| AM-Pharma | 77% | |
| ePurines, Inc. | 77% |
Kantum Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 12, 2021 | ||||
| Seed | Nov 22, 2019 | ||||
| Grant | Nov 15, 2017 |
Kantum Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Series A |
| 10x Venture Partners | Series A |
| Millworks Fund | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2021
$4M round with participation from 10x Venture Partners and Broadview Ventures.
Kantum Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kantum Pharma's valuation, stock price, and market status.
Is Kantum Pharma a public or private company?
Kantum Pharma is a private company.
What is the current stock price of Kantum Pharma?
Kantum Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Kantum Pharma worth (valuation)?
Valuation information for Kantum Pharma is not publicly available.
Can I buy Kantum Pharma stock?
Kantum Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kantum Pharma's last funding round?
Kantum Pharma's most recent funding round was Series A on July 12, 2021.
Who are the main investors in Kantum Pharma?
Key investors in Kantum Pharma include SideCar Angels, 10x Venture Partners, Millworks Fund, Broadview Ventures.
Will Kantum Pharma IPO soon?
No public IPO plans have been announced for Kantum Pharma.
How can I track Kantum Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kantum Pharma's secondary market activity and sign up for updates.